Literature DB >> 16687415

Functional interplay between BRCA2/FancD1 and FancC in DNA repair.

Hiroyuki Kitao1, Kazuhiko Yamamoto, Nobuko Matsushita, Mioko Ohzeki, Masamichi Ishiai, Minoru Takata.   

Abstract

A rare hereditary disorder, Fanconi anemia (FA), is caused by mutations in an array of genes, which interact in a common FA pathway/network. These genes encode components of the FA "core" complex, a key factor FancD2, the familial breast cancer suppressor BRCA2/FancD1, and Brip1/FancJ helicase. Although BRCA2 is known to play a pivotal role in homologous recombination repair by regulating Rad51 recombinase, the precise functional relationship between BRCA2 and the other FA genes is unclear. Here we show that BRCA2-dependent chromatin loading of Rad51 after mitomycin C treatment was not compromised by disruption of FANCC or FANCD2. Rad51 and FancD2 form colocalizing subnuclear foci independently of each other. Furthermore, we created a conditional BRCA2 truncating mutation lacking the C-terminal conserved domain (CTD) (brca2DeltaCTD), and disrupted the FANCC gene in this background. The fancc/brca2DeltaCTD double mutant revealed an epistatic relationship between FANCC and BRCA2 CTD in terms of x-ray sensitivity. In contrast, levels of cisplatin sensitivity and mitomycin C-induced chromosomal aberrations were increased in fancc/brca2DeltaCTD cells relative to either single mutant. Taken together, these results indicate that FA proteins work together with BRCA2/Rad51-mediated homologous recombination in double strand break repair, whereas the FA pathway plays a role that is independent of the CTD of BRCA2 in interstrand cross-link repair. These results provide insights into the functional interplay between the classical FA pathway and BRCA2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687415     DOI: 10.1074/jbc.M603290200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.

Authors:  Xiaoyong Chen; James B Wilson; Patricia McChesney; Stacy A Williams; Youngho Kwon; Simonne Longerich; Andrew S Marriott; Patrick Sung; Nigel J Jones; Gary M Kupfer
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

2.  Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.

Authors:  Kerstin Knies; Shojiro Inano; María J Ramírez; Masamichi Ishiai; Jordi Surrallés; Minoru Takata; Detlev Schindler
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

3.  A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.

Authors:  Curtis R Warren; Zohra Ali-Khan Catts; Mary C Farach-Carson
Journal:  Exp Cell Res       Date:  2011-06-29       Impact factor: 3.905

4.  The phenotype of FancB-mutant mouse embryonic stem cells.

Authors:  Tae Moon Kim; Jun Ho Ko; Yong Jun Choi; Lingchuan Hu; Paul Hasty
Journal:  Mutat Res       Date:  2011-03-30       Impact factor: 2.433

5.  Characterization of environmental chemicals with potential for DNA damage using isogenic DNA repair-deficient chicken DT40 cell lines.

Authors:  Kimiyo N Yamamoto; Kouji Hirota; Koichi Kono; Shunichi Takeda; Srilatha Sakamuru; Menghang Xia; Ruili Huang; Christopher P Austin; Kristine L Witt; Raymond R Tice
Journal:  Environ Mol Mutagen       Date:  2011-04-27       Impact factor: 3.216

Review 6.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

7.  Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction.

Authors:  Gang Zhi; James B Wilson; Xiaoyong Chen; Diane S Krause; Yuxuan Xiao; Nigel J Jones; Gary M Kupfer
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

Review 8.  Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.

Authors:  Paul R Andreassen; Keqin Ren
Journal:  Curr Cancer Drug Targets       Date:  2009-02       Impact factor: 3.428

9.  FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.

Authors:  Masamichi Ishiai; Hiroyuki Kitao; Agata Smogorzewska; Junya Tomida; Aiko Kinomura; Emi Uchida; Alihossein Saberi; Eiji Kinoshita; Emiko Kinoshita-Kikuta; Tohru Koike; Satoshi Tashiro; Stephen J Elledge; Minoru Takata
Journal:  Nat Struct Mol Biol       Date:  2008-10-19       Impact factor: 15.369

10.  Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.

Authors:  Marianne Berwick; Jaya M Satagopan; Leah Ben-Porat; Ann Carlson; Katherine Mah; Rashida Henry; Raffaella Diotti; Kelly Milton; Kanan Pujara; Tom Landers; Sat Dev Batish; José Morales; Detlev Schindler; Helmut Hanenberg; Robert Hromas; Orna Levran; Arleen D Auerbach
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.